vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Rumble Inc. (RUM). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $27.1M, roughly 1.7× Rumble Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -120.8%, a 100.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -10.5%). Rumble Inc. produced more free cash flow last quarter ($-31.7M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 15.2%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".

ABCL vs RUM — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.7× larger
ABCL
$44.9M
$27.1M
RUM
Growing faster (revenue YoY)
ABCL
ABCL
+798.8% gap
ABCL
788.4%
-10.5%
RUM
Higher net margin
ABCL
ABCL
100.8% more per $
ABCL
-19.9%
-120.8%
RUM
More free cash flow
RUM
RUM
$12.9M more FCF
RUM
$-31.7M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
15.2%
RUM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
RUM
RUM
Revenue
$44.9M
$27.1M
Net Profit
$-8.9M
$-32.7M
Gross Margin
5.5%
Operating Margin
-63.7%
-131.1%
Net Margin
-19.9%
-120.8%
Revenue YoY
788.4%
-10.5%
Net Profit YoY
73.9%
86.2%
EPS (diluted)
$-0.03
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
RUM
RUM
Q4 25
$44.9M
$27.1M
Q3 25
$9.0M
$24.8M
Q2 25
$17.1M
Q1 25
$4.2M
$23.7M
Q4 24
$5.0M
$30.2M
Q3 24
$6.5M
$25.1M
Q2 24
$7.3M
$22.5M
Q1 24
$10.0M
$17.7M
Net Profit
ABCL
ABCL
RUM
RUM
Q4 25
$-8.9M
$-32.7M
Q3 25
$-57.1M
$-16.3M
Q2 25
$-34.7M
Q1 25
$-45.6M
$-2.7M
Q4 24
$-236.8M
Q3 24
$-51.1M
$-31.5M
Q2 24
$-36.9M
$-26.8M
Q1 24
$-40.6M
$-43.3M
Gross Margin
ABCL
ABCL
RUM
RUM
Q4 25
5.5%
Q3 25
-1.8%
Q2 25
Q1 25
-26.7%
Q4 24
-14.2%
Q3 24
-45.4%
Q2 24
-58.8%
Q1 24
-79.5%
Operating Margin
ABCL
ABCL
RUM
RUM
Q4 25
-63.7%
-131.1%
Q3 25
-851.8%
-113.6%
Q2 25
-290.2%
Q1 25
-1479.6%
-153.5%
Q4 24
-80.1%
Q3 24
-1439.4%
-131.0%
Q2 24
-1276.2%
-172.7%
Q1 24
-551.5%
-197.4%
Net Margin
ABCL
ABCL
RUM
RUM
Q4 25
-19.9%
-120.8%
Q3 25
-637.8%
-65.7%
Q2 25
-203.3%
Q1 25
-1077.2%
-11.2%
Q4 24
-783.2%
Q3 24
-785.4%
-125.9%
Q2 24
-504.3%
-119.2%
Q1 24
-408.0%
-244.1%
EPS (diluted)
ABCL
ABCL
RUM
RUM
Q4 25
$-0.03
$-0.13
Q3 25
$-0.19
$-0.06
Q2 25
$-0.12
Q1 25
$-0.15
$-0.01
Q4 24
$-1.17
Q3 24
$-0.17
$-0.15
Q2 24
$-0.13
$-0.13
Q1 24
$-0.14
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
RUM
RUM
Cash + ST InvestmentsLiquidity on hand
$128.5M
$237.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$274.8M
Total Assets
$1.4B
$336.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
RUM
RUM
Q4 25
$128.5M
$237.9M
Q3 25
$83.2M
$269.8M
Q2 25
$92.4M
Q1 25
$159.3M
$301.3M
Q4 24
$156.3M
$114.0M
Q3 24
$126.6M
$132.0M
Q2 24
$148.3M
$154.2M
Q1 24
$123.6M
$183.8M
Stockholders' Equity
ABCL
ABCL
RUM
RUM
Q4 25
$966.9M
$274.8M
Q3 25
$964.0M
$302.2M
Q2 25
$1.0B
Q1 25
$1.0B
$339.6M
Q4 24
$1.1B
$-63.1M
Q3 24
$1.1B
$166.1M
Q2 24
$1.1B
$192.7M
Q1 24
$1.1B
$210.7M
Total Assets
ABCL
ABCL
RUM
RUM
Q4 25
$1.4B
$336.8M
Q3 25
$1.4B
$367.2M
Q2 25
$1.4B
Q1 25
$1.3B
$391.1M
Q4 24
$1.4B
$195.3M
Q3 24
$1.4B
$217.2M
Q2 24
$1.4B
$243.2M
Q1 24
$1.5B
$263.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
RUM
RUM
Operating Cash FlowLast quarter
$-34.7M
$-29.4M
Free Cash FlowOCF − Capex
$-44.6M
$-31.7M
FCF MarginFCF / Revenue
-99.4%
-117.2%
Capex IntensityCapex / Revenue
21.9%
8.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$-70.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
RUM
RUM
Q4 25
$-34.7M
$-29.4M
Q3 25
$-52.6M
$-10.6M
Q2 25
$-32.4M
Q1 25
$-11.6M
$-14.5M
Q4 24
$-108.6M
$-12.4M
Q3 24
$-28.9M
$-19.1M
Q2 24
$-30.0M
$-21.7M
Q1 24
$-41.7M
$-33.9M
Free Cash Flow
ABCL
ABCL
RUM
RUM
Q4 25
$-44.6M
$-31.7M
Q3 25
$-61.5M
$-12.0M
Q2 25
$-45.8M
Q1 25
$-22.2M
$-14.6M
Q4 24
$-187.0M
$-12.4M
Q3 24
$-47.4M
$-19.9M
Q2 24
$-50.1M
$-23.1M
Q1 24
$-65.8M
$-34.3M
FCF Margin
ABCL
ABCL
RUM
RUM
Q4 25
-99.4%
-117.2%
Q3 25
-687.0%
-48.6%
Q2 25
-267.9%
Q1 25
-524.0%
-61.7%
Q4 24
-3702.8%
-40.9%
Q3 24
-728.4%
-79.5%
Q2 24
-683.8%
-102.8%
Q1 24
-661.5%
-193.3%
Capex Intensity
ABCL
ABCL
RUM
RUM
Q4 25
21.9%
8.5%
Q3 25
99.7%
5.7%
Q2 25
78.2%
Q1 25
251.1%
0.6%
Q4 24
1552.7%
0.1%
Q3 24
284.6%
3.4%
Q2 24
274.6%
6.1%
Q1 24
242.5%
2.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

RUM
RUM

Audience Monetization$23.8M88%
Other Initiatives$3.3M12%

Related Comparisons